Risk of Thromboembolism Associated With Atrial Fibrillation Following Noncardiac Surgery

被引：99

作者：

Butt, Jawad H. ^{[1
]}

Olesen, Jonas B. ^{[2
,6
,7
,8
,9
,10
,11
]}

Havers-Borgersen, Eva ^{[1
]}

Gundlund, Anna ^{[2
]}

Andersson, Charlotte ^{[2
]}

Gislason, Gunnar H. ^{[2
,3
,4
]}

Torp-Pedersen, Christian ^{[5
]}

Kober, Lars ^{[1
]}

Fosbol, Emil L. ^{[1
]}

机构：

[1] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark

[2] Herlev & Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark

[3] Danish Heart Fdn, Copenhagen, Denmark

[4] Univ Southern Denmark, Natl Inst Publ Hlth, Odense, Denmark

[5] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark

[6] Bristol Myers Squibb, New York, NY USA

[7] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany

[8] Bayer, Leverkusen, Germany

[9] AstraZeneca, Cambridge, England

[10] Novartis Healthcare, Basel, Switzerland

[11] Novo Nordisk, Bagsvaerd, Denmark

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 72卷 / 17期

关键词：

atrial fibrillation; epidemiology; surgery; thromboembolism; LONG-TERM RISK; NEW-ONSET; CARDIAC-SURGERY; STROKE; ARRHYTHMIAS; MANAGEMENT; DIAGNOSES; VALIDITY; OUTCOMES; THERAPY;

D O I：

10.1016/j.jacc.2018.07.088

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

BACKGROUND The long-term risk of thromboembolism in patients developing new-onset post-operative atrial fibrillation (POAF) following noncardiac surgery is unknown, and data on stroke prophylaxis in this setting are lacking. OBJECTIVES The purpose of this study was to assess the long-term risk of thromboembolism in patients developing new-onset POAF following noncardiac surgery relative to patients with nonsurgical, nonvalvular atrial fibrillation (NVAF). METHODS Using Danish nationwide registries, the authors identified all patients who developed POAF following noncardiac surgery from 1996 to 2015. These were matched by age, sex, heart failure, hypertension, diabetes, previous thromboembolism, ischemic heart disease, and year of diagnosis to patients with nonsurgical NVAF in a 1: 4 ratio. Comparative long-term risk of thromboembolism was examined by multivariable Cox regression models. RESULTS In patients undergoing noncardiac surgery, 6,048 (0.4%) developed POAF during hospitalization, with the highest incidences following thoracic/pulmonary, vascular, and abdominal surgery. A total of 3,830 patients with POAF were matched with 15,320 patients with NVAF. Oral anticoagulation therapy was initiated within 30 days post-discharge in 24.3% and 41.3% of these patients, respectively (p value < 0.001). The long-term risk of thromboembolism was similar in patients with POAF and NVAF (31.7 events vs. 29.9 events per 1,000 person years; hazard ratio [HR]: 0.95; 95% confidence interval [CI]: 0.85 to 1.07). Anticoagulation therapy during follow-up was associated with a comparably lowered risk of thromboembolic events in patients with POAF (HR: 0.52; 95% CI: 0.40 to 0.67) as well as NVAF (HR: 0.56; 95% CI: 0.51 to 0.62) compared with no anticoagulation therapy. CONCLUSIONS New-onset POAF following noncardiac surgery was associated with a long-term risk of thromboembolism similar to NVAF. (c) 2018 by the American College of Cardiology Foundation.

引用

页码：2027 / 2036

页数：10

共 34 条

[1] Postoperative atrial fibrillation in non-cardiac and cardiac surgery: an overview [J].